In situ synthesized BSA capped gold nanoparticles: Effective carrier of anticancer drug Methotrexate to MCF-7 breast cancer cells

Materials Science and Engineering C

Volumn 34, Issue 1, 2014, Pages 158-167

  Murawala, Priyanka ^a   Tirmale, Amruta ^a,b   Shiras, Anjali ^b   Prasad, B L V ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Apoptosis; Bovine serum albumin; Cancer therapy; Cytotoxicity; Dual active agents; Gold nanoparticles

Indexed keywords

ACTIVE AGENTS; BOVINE SERUM ALBUMINS; BREAST CANCER CELLS; CANCER THERAPY; GEL ELECTROPHORESIS; GOLD NANOPARTICLES; IN-SITU SYNTHESIZED; MCF-7 BREAST CANCER CELLS;

ASSAYS; CELL DEATH; CYTOTOXICITY; ELECTROPHORESIS; GOLD;

METAL NANOPARTICLES;

ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; CASPASE 3; DRUG CARRIER; GOLD; GOLD NANOPARTICLE; KI 67 ANTIGEN; METAL NANOPARTICLE; METHOTREXATE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BREAST TUMOR; CANCER THERAPY; CELL CYCLE; CHEMISTRY; CYTOTOXICITY; DRUG EFFECT; DUAL ACTIVE AGENTS; FEMALE; HUMAN; INFRARED SPECTROSCOPY; MCF 7 CELL LINE; METABOLISM; ULTRASTRUCTURE;

APOPTOSIS; BOVINE SERUM ALBUMIN; CANCER THERAPY; CYTOTOXICITY; DUAL ACTIVE AGENTS; GOLD NANOPARTICLES;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; DRUG CARRIERS; ELECTROPHORESIS, AGAR GEL; FEMALE; GOLD; HUMANS; KI-67 ANTIGEN; MCF-7 CELLS; METAL NANOPARTICLES; METHOTREXATE; SERUM ALBUMIN, BOVINE; SPECTROPHOTOMETRY, ATOMIC; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84889094594     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2013.09.004     Document Type: Article

References (60)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin GLOBOCAN, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] 2008 International Agency for Research on Cancer Lyon, France
2. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20 (Pubitemid 32144788)
3. M.L. Hans, and A.M. Lowman Biodegradable nanoparticles for drug delivery and targeting Curr. Opin. Solid State Mater. Sci. 6 2002 319 327 (Pubitemid 36238389)
4. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347 (Pubitemid 36297053)
5. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
6. J.R. Baker Jr. Dendrimer-based nanoparticles for cancer therapy Hematology 2009 2009 708 719
7. E.R. Gillies, and J.M.J. Frechet Dendrimers and dendritic polymers in drug delivery Drug Discov. Today 10 2005 35 43 (Pubitemid 40164817)
8. C.C. Lee, J.A. MacKay, J.M.J. Fréchet, and F.C. Szoka Designing dendrimers for biological applications Nat. Biotechnol. 23 2005 1517 1526 (Pubitemid 41752929)
9. M. Liu, and J.M.J. Fréchet Designing dendrimers for drug delivery Pharm. Sci. Technol. Today 2 1999 393 401 (Pubitemid 29452933)
10. A. Sharma, and U.S. Sharma Liposomes in drug delivery: progress and limitations Int. J. Pharm. 154 1997 123 140 (Pubitemid 27351317)
11. G. Gregoriadis Engineering liposomes for drug delivery: progress and problems Trends Biotechnol. 13 1995 527 537
12. A. Puri, K. Loomis, B. Smith, J.H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit. Rev. Ther. Drug Carrier Syst. 26 2009 523 580
13. E. Boisselier, and D. Astruc Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity Chem. Soc. Rev. 38 2009 1759 1782
14. M.C. Daniel, and D. Astruc Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology Chem. Rev. 104 2004 293 346
15. C.M. Niemeyer Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science Angew. Chem. Int. Ed. 40 2001 4128 4158
16. D.A. Giljohann, D.S. Seferos, W.L. Daniel, M.D. Massich, P.C. Patel, and C.A. Mirkin Gold nanoparticles for biology and medicine Angew. Chem. Int. Ed. 49 2010 3280 3294
17. O.V. Salata Applications of nanoparticles in biology and medicine J. Nanobiotechnol. 2 3 2004 1 6
18. P.K. Jain, X. Huang, I.H. El-Sayed, and M.A. El-Sayed Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine Acc. Chem. Res. 41 2008 1578 1586
19. M. De, P.S. Ghosh, and V.M. Rotello Applications of nanoparticles in biology Adv. Mater. 20 2008 4225 4241
20. G. Han, P. Ghosh, and V.M. Rotello Functionalized gold nanoparticles for drug delivery Nanomedicine 2 2007 113 123 (Pubitemid 46845782)
21. S. Dhar, E.M. Reddy, A. Shiras, V. Pokharkar, and B.L.V. Prasad Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations Chem. Eur. J. 14 2008 10244 10250
22. F. Kratz Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J. Control. Release 132 2008 171 183
23. G. Stehle, A. Wunder, H. Sinn, H.H. Schrenk, S. Schiitt, E. Frei, G. Hartung, W. Maier-Borst, and D.L. Heene Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats Anticancer Drugs 8 1997 835 844 (Pubitemid 27487797)
24. G. Stehle, H. Sinn, A. Wunder, H.H. Schrenk, S. Schütt, W. Maier-Borst, and D.L. Heene The loading rate determines tumor targeting properties of methotrexate albumin conjugates in rats Anticancer Drugs 8 1997 667 672
25. A. Vis, A. van der Gaast, B. van Rhijn, T. Catsburg, C. Schmidt, and G. Mickisch A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy Cancer Chemother. Pharmacol. 49 2002 342 345 (Pubitemid 34253274)
26. C. Fiehn, U. Muller-Ladner, S. Gay, S. Krienke, S. Freudenberg-Konrad, J. Funk, A.D. Ho, H. Sinn, and A. Wunder Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX Rheumatology 43 2004 1097 1105 (Pubitemid 39232813)
27. F. Kratz, A. Warnecke, K. Scheuermann, C. Stockmar, J. Schwab, P. Lazar, P. Druckes, N. Esser, J. Drevs, and D. Rognan Probing The cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound J. Med. Chem. 45 2002 5523 5533 (Pubitemid 35424970)
28. F. Kratz, G. Ehling, H.M. Kauffmann, and C. Unger Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl) hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin Hum. Exp. Toxicol. 26 2007 19 35
29. C. Unger, B. Häring, M. Medinger, J. Drevs, S. Steinbild, F. Kratz, and K. Mross Phase I and pharmacokinetic study of the (6-maleimidocaproyl) hydrazone derivative of doxorubicin Clin. Cancer Res. 13 2007 4858 4866 (Pubitemid 47294793)
30. N.K. Ibrahim, B. Samuels, R. Page, D. Doval, K.M. Patel, S.C. Rao, M.K. Nair, P. Bhar, N. Desai, and G.N. Hortobagyi Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer J. Clin. Oncol. 23 2005 6019 6026
31. W.J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Desai, P. Bhar, M. Hawkins, and J. O'Shaughnessy Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J. Clin. Oncol. 23 2005 7794 7803 (Pubitemid 46657376)
32. M.R. Green, G.M. Manikhas, S. Orlov, B. Afanasyev, A.M. Makhson, P. Bhar, and M.J. Hawkins Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 17 2006 1263 1268 (Pubitemid 44288216)
33. P. Kurtzhals, S. Havelund, I. Jonassen, and J. Markussen Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue J. Pharm. Sci. 86 1997 1365 1368 (Pubitemid 28018315)
34. P. Home, and P. Kurtzhals Insulin detemir: from concept to clinical experience Expert. Opin. Pharmacother. 7 2006 325 343 (Pubitemid 43263250)
35. A.T. Chemmanur, and G.Y. Wu Drug evaluation: albuferon-alpha  - an antiviral interferon-a/albumin fusion protein Curr. Opin. Investig. Drugs 7 2006 750 758 (Pubitemid 44268848)
36. R.J. Melder, B.L. Osborn, T. Riccobene, P. Kanakaraj, P. Wei, G. Chen, D. Stolow, W.G. Halpern, T.S. Migone, and Q. Wang Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice Cancer Immunol. Immunother. 54 2005 535 547
37. R. Sinha, G.J. Kim, S. Nie, and D.M. Shin Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery Mol. Cancer Ther. 5 2006 1909 1917 (Pubitemid 44336561)
38. W.A. Bleyer The clinical pharmacology of methotrexate: new applications of an old drug Cancer 41 1978 36 51 (Pubitemid 8286409)
39. K.L. Young, C. Xu, J. Xie, and S. Sun Conjugating Methotrexate to magnetite (Fe3O4) nanoparticles via trichloro-s-triazine J. Mater. Chem. 19 2009 6400 6406
40. J.W. Park Liposome-based drug delivery in breast cancer treatment Breast Cancer Res. 4 2002 95 99 (Pubitemid 34520734)
41. N. Kohler, C. Sun, J. Wang, and M. Zhang Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells Langmuir 21 2005 8858 8864 (Pubitemid 41396647)
42. X. Zhang, F. Chen, and J. Ni A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system Drug Deliv. 16 2009 280 288
43. N. Kohler, C. Sun, A. Fichtenholtz, J. Gunn, C. Fang, and M. Zhang Methotrexate-immobilized poly (ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery Small 2 2006 785 792 (Pubitemid 43745151)
44. Y.H. Chen, C.Y. Tsai, P.Y. Huang, M.Y. Chang, P.C. Cheng, C.H. Chou, D.H. Chen, C.R. Wang, A.L. Shiau, and C.L. Wu Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model Mol. Pharm. 4 2007 713 722
45. P. Murawala, S.M. Phadnis, R.R. Bhonde, and B.L.V. Prasad In situ synthesis of water dispersible bovine serum albumin capped gold and silver nanoparticles and their cytocompatibility studies Colloids Surf. B: Biointerfaces 73 2009 224 228
46. T. Mossmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays Immunol. Methods 65 1983 55 58
47. A. Rangnekar, T.K. Sarma, A.K. Singh, J. Deka, A. Ramesh, and A. Chattopadhyay Retention of enzymatic activity of α-amylase in the reductive synthesis of gold nanoparticles Langmuir 23 2007 5700 5706 (Pubitemid 46826525)
48. E. Katz, and I. Willner Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications Angew. Chem. Int. Ed. 43 2004 6042 6108 (Pubitemid 39611873)
49. R. Lévy, N.T.K. Thanh, R.C. Doty, I. Hussain, R.J. Nichols, D.J. Schiffrin, M. Brust, and D.G. Fernig Rational and combinatorial design of peptide capping ligands for gold nanoparticles J. Am. Chem. Soc. 126 2004 10076 10084 (Pubitemid 39079430)
50. J. Liu, G. Qin, P. Raveendran, and Y. Ikushima Facile "green" synthesis, characterization, and catalytic function of β-D-glucose- stabilized Au nanocrystals Chem. Eur. J. 12 2006 2131 2138 (Pubitemid 43344534)
51. P. Mulvaney Surface plasmon spectroscopy of nanosized metal particles Langmuir 12 1996 788 800 (Pubitemid 126568066)
52. D.S. Goodsell The molecular perspective: methotrexate Oncologist 4 1999 340 341 (Pubitemid 29409311)
53. T. Scholzen, and J. Gerdes The Ki-67 protein: from the known and the unknown J. Cell. Physiol. 182 2000 311 322 (Pubitemid 30054364)
54. R.J. Bold, P.M. Termuhlen, and D.J. McConkey Apoptosis, cancer and cancer therapy Surg. Oncol. 6 1997 133 142 (Pubitemid 28119138)
55. S. Mazumder, D. Plesca, and A. Almasan Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis Methods Mol. Biol. 414 2008 13 21
56. I. Herr, and K.M. Debatin Cellular stress response and apoptosis in cancer therapy Blood 98 2001 2603 2614
57. M.J. Arends, R.G. Morris, and A.H. Wyllie Apoptosis. The role of the endonuclease Am. J. Pathol. 136 1990 593 608 (Pubitemid 20105927)
58. I.W. Taylor, and M.H.N. Tattersall Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry Cancer Res. 41 1981 1549 1558 (Pubitemid 11146795)
59. J.C. Li, and E. Kaminskas Accumulation of DNA strand breaks and methotrexate cytotoxicity Proc. Natl. Acad. Sci. U. S. A. 81 1984 5694 5698 (Pubitemid 14023832)
60. B. Celtikci, A.K. Lawrance, Q. Wu, and R. Rozen Methotrexate induced apoptosis is enhanced by altered expression of methylenetetrahydrofolate reductase Anticancer Drugs 20 2009 787 793